Tetraneuron
Valencia
About Tetraneuron
Tetraneuron is a gene therapy biotech company. They develop disruptive multifactorial gene therapy to treat Alzheimer’s disease and a biomarker for early detection of this disease. They respond to customer inquiries by contact form and email.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 11 – 50
- Estimated revenue: $1K – $10K
- Total funding: $14.5M
- Last round: Series Unknown (Dec 2025)
- Website: tetraneuron.com
- Phone: +34 915854740
Industries & Categories
Biotechnology, Medical, Neuroscience, Pharmaceutical
Social Profiles
Canonical: https://fsome.com/organization/tetraneuron-25333 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.